Protara Therapeutics, Inc.
TARA· Nasdaq
TARAProtara Therapeutics, Inc.
Filed Mar 9, 2022 · 10-K · 68 days after period end · 0001213900-22-011208
derived · Computed from the longer spans the company filed.
| Metric | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures | Q4 2019dderived from reported figures | Q4 2018 |
|---|---|---|---|---|
| Net Income | -$10.23M | -$8.81M | -$1.61M | -$5.26M |
| EPS Diluted | — | — | — | -$0.27 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Protara Therapeutics, Inc. · CIK 1359931 · Engraved from SEC EDGAR
ended Dec 31, 2021 · filed Mar 9, 2022 · 68 d after period end
